Utility of Follow-Up of 131I-MIBG Scintigraphy to Screen Pheochromocytoma

被引：0
作者：
Watanabe, Satoshi [1 ]
Kahara, Toshio [1 ]
Seto, Chikashi [2 ]
Uchiyama, Akio [3 ]
Abo, Hitoshi [4 ]
Ishikura, Kazuhide [1 ]
Nakajima, Ken-ichi [5 ]
Usuda, Rika [1 ]
机构：
[1] Toyama Prefectural Cent Hosp, Dept Internal Med, Toyama, Japan
[2] Toyama Prefectural Cent Hosp, Dept Urol, Toyama, Japan
[3] Toyama Prefectural Cent Hosp, Dept Clin Pathol, Toyama, Japan
[4] Toyama Prefectural Cent Hosp, Dept Radiol, Toyama, Japan
[5] Kanazawa Univ Hosp, Dept Nucl Med, Kanazawa, Ishikawa, Japan
来源：
INTERNAL MEDICINE | 2009年 / 48卷 / 18期
关键词：
I-131-MIBG scintigraphy; pheochromocytoma; paraganglioma; MIBG therapy;
D O I：
10.2169/internalmedicine.48.2507
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1711 / 1712
页数：2
相关论文
共 50 条
  • [21] Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma
    Ferdinand Sudbrock
    Matthias Schmidt
    Thorsten Simon
    Wolfgang Eschner
    Frank Berthold
    Harald Schicha
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 1279 - 1290
  • [22] Paraganglioma From Vaginal Wall Revealed by 131I-MIBG Scan
    Zheng, Kun
    Zhu, Shikun
    Chen, Libo
    Li, Fang
    Jing, Hongli
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (08) : 691 - 693
  • [23] Dosimetry in 131I-MIBG therapy: moving toward personalized medicine
    Chiesa, C.
    Castellani, R.
    Mira, M.
    Lorenzoni, A.
    Flux, G. D.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 57 (02) : 161 - 170
  • [24] Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma
    George, Sally L.
    Falzone, Nadia
    Chittenden, Sarah
    Kirk, Stephanie J.
    Lancaster, Donna
    Vaidya, Sucheta J.
    Mandeville, Henry
    Saran, Frank
    Pearson, Andrew D. J.
    Du, Yong
    Meller, Simon T.
    Denis-Bacelar, Ana M.
    Flux, Glenn D.
    NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (05) : 466 - 472
  • [25] Treatment of metastatic pheochromocytoma and paraganglioma with 131I-meta-iodobenzylguanidine (MIBG)
    Kaltsas, GA
    Mukherjee, JJ
    Foley, R
    Britton, KE
    Grossman, AB
    ENDOCRINOLOGIST, 2003, 13 (04) : 321 - 333
  • [26] Efficacy of using a standard activity of 131I-MIBG therapy in patients with disseminated neuroendocrine tumours
    Navalkissoor, Shaunak
    Alhashimi, Dona M.
    Quigley, Ann-Marie
    Caplin, Martyn E.
    Buscombe, John R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (05) : 904 - 912
  • [27] Malignant pheochromocytomas and paragangliomas -: A phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG)
    Fitzgerald, Paul A.
    Goldsby, Robert E.
    Huberty, John P.
    Price, David C.
    Hawkins, Randall A.
    Veatch, Janet J.
    Dela Cruz, Filemon
    Jahan, Thierry M.
    Linker, Charles A.
    Damon, Lloyd
    Matthay, Katherine K.
    PHEOCHROMOCYTOMA, 2006, 1073 : 465 - 490
  • [28] Combined Treatment With 131I-MIBG and Sunitinib Induces Remission in a Patient With Metastatic Paraganglioma Due to Hereditary Paraganglioma-Pheochromocytoma Syndrome From an SDHB Mutation
    Makis, William
    McCann, Karey
    McEwan, Alexander J. B.
    Sawyer, Michael B.
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (03) : 204 - 206
  • [29] Pheochromocytoma and Paraganglioma: From Treatment to Follow-up
    Aygun, Nurcihan
    Uludag, Mehmet
    MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, 2020, 54 (04): : 391 - 398
  • [30] The treatment of malignant metaiodobenzylguanidine (131I-MIBG):: A comprehensive review of 116 reported patients
    Loh, KC
    Fitzgerald, PA
    Matthay, KK
    Yeo, PPB
    Price, DC
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1997, 20 (11) : 648 - 658
12345